Navigation Links
New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease

The discovery that bone-marrow derived stem cells can regenerate damaged renal cells in an animal model of Alport syndrome provides a potential new strategy for managing this inherited kidney disease and offers the first example of how stem cells may be useful in repairing basement membrane matrix defects and restoring organ function.

Led by researchers at Beth Israel Deaconess Medical Center (BIDMC), the findings are described in the Proceedings of the National Academy of Sciences (PNAS), which appears on-line the week of April 24, 2006.

Symptoms of Alport syndrome, the second most common genetic cause of kidney failure, usually appear in children, affecting the kidneys' filtration system and typically leading to end-stage renal disease in the patient's teens, 20s or 30s. The disease additionally causes deafness in some patients.

"This is one of 31 human diseases that occur because of genetic defects in the body's extracellular matrix and basement membrane proteins, " explains the study's senior author Raghu Kalluri, PhD, chief of the division of matrix biology at BIDMC and associate professor of medicine at Harvard Medical School.

Present throughout the body, the extracellular matrix (ECM) is made of collagens, proteogylcans, noncollagenous glycoproteins and in some tissues, elastin fibers. The ECM serves a unique role by constructing a "scaffold" for cells, thereby maintaining the structural integrity of many tissues.

"In normal kidneys, a specialized form of extracellular matrix known as the glomerular basement membrane [GBM], composed primarily of type IV collagen, is the key component of the blood filtration apparatus," says Kalluri.

However, in patients with Alport syndrome, mutations in three different type IV collagen genes cause structural damage to the GBM, leading to a breakdown of the organ's filtration system, and resulting in the seepage of blood and protein into the urine and eventual kidney failure.<
'"/>

Source:Beth Israel Deaconess Medical Center


Page: 1 2

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/4/2009)... Long Beach and Riverside are responsible for a si...ma, and the true impact of air pollution and ship ...mated, according to researchers at the University ...h appears in an online edition of the American Jo...nt of all childhood asthma cases in Long Beach and...
(Date:11/4/2009)... the DNA codes, or genomes, of the famed fugu (or ...ome 10K Project, an international effort to build ...0 species of animals for conducting comparative st...d. , Participating in The Genome 10K project, de...ssue of the Journal of Heredity , are 70 leading ...
(Date:11/4/2009)...irstCall/ -- Quest Diagnostics Incorporated (NYSE:...c testing, information and services, announced tha...income from continuing operations rose to $192 mil...n, or $0.81 per diluted share, for the third quart...duced by a $0.03 per share charge associated with ...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 1Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 2Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 3New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 1New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 2New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7
... where and how some plant seeds store iron, a valu...he iron content of plants. Their research helps ad... malnutrition in humans. , The team found that iro...he seed of Arabidopsis, a model plant used in rese..., a plant cell,s central storage site. The researc...
...oxycycline effectively treats a type of lymphoma a... study in the October 4 issue of the Journal of ...lymphoma of the MALT-type (OAL) is a kind of cance...ten fatal, but its symptoms can compromise a patie...an association between OAL and infection with the ...
...nia Bioinformatics Institute and Duke University M...ppears to play an important role in the developmen...assicicola, a destructive fungal pathogen that cau... crops worldwide, results in considerable leaf los...anola, cabbage and broccoli. Sensitivity to spore...
Other Biology News:Plant studies reveal how, where seeds store iron 2Tearing down the fungal cell wall 2Tearing down the fungal cell wall 3
(Date:11/5/2009)...v. 5 Imagenetix, Inc. (O...liam Spencer, President and CEO of Imagenetix, wil...ual LD MICRO Conference on Thursday, December 3rd,.... ,, About LD MICRO ,, LD MICRO is a by-invi...g undervalued companies in the micro-cap space. Si...
(Date:11/5/2009)...ll on Thursday, November 5, 2009 at 4:30 p.m. East...PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals,...I ) today reported unaudited financial results for... 30, 2009 and reviewed the Company,s highlights fo...onsolidated results reflect the operations of Onco...
(Date:11/5/2009)...., Nov. 5 BioSpecifics T...tical company developing first-in-class collagenas...sults for the third quarter ended September 30, 20...mber of this year, the FDA,s Arthritis Advisory Co..., the approval of XIAFLEX(TM) for the treatment of...
(Date:11/5/2009)...exas, Nov. 5 Wound Manag...that it has entered into a Letter of Intent to pur...lth Technologies, Inc. (OTC Bulletin Board: VHGI)....in cash and debt, 4,000,000 shares of WNDM and a r... the Veriscrip technology being acquired from VHGI...
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ewswire-FirstCall/ - Neptune Technologies & Bi...NTB) provides an update on business activities reg...Sales and Distribution Update, - Neptune expand... of two, additional marketing and sales execu...ckgrounds in the nutraceutical and functional food...
...(May 4, 2009): Uveitis, or inflammation within the... of visual loss roughly comparable to that caused ...ational Phase 3 program in uveitis, the LUMINATE t...e ability of LX211 (LUVENIQ, voclosporin oral caps...lammation. Additionally, in patients who are disco...
... Novavax, Inc. (Nasdaq: NVAX ) today announced ...al results in a press release to be issued after 8...Company will hold an investor conference call to d... Time on Friday, May 8, 2009. The call will be hos...er Dr. Rahul Singhvi and other members of senior m...
Other Biology Technology:Neptune Product and Distribution Update 2Neptune Product and Distribution Update 3Neptune Product and Distribution Update 4First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 2First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 3First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 4Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call 2
Bulk Enzymes/Bulk Proteins from Molecular Biology Resources
...rom balances and scales with RS232 ports and sends...f you can type the weight into the program, Balanc...mple to use parser extracts required data , Add da...llect data at timed intervals , Keyboard macros au...
Rabbit Anti-Human Prolactin Releasing Hormone Receptor (GPR10) Polyclonal Antibody, Unconjugated from IMGENEX
...ance data collection and automation that is contro...h Microsoft Excel , Pre-configured library of int...s , New balances can be added and configured by th...o one spreadsheet , Allows for multi-tasking dur...
Biology Products: